Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.
Bednarczyk
E M
EM
Division of Cardiology, University Hospitals of Cleveland, Ohio 44106.
White
W B
WB
Munger
M A
MA
Gonzalez
F M
FM
Panacek
E A
EA
Weed
S G
SG
Rutherford
W F
WF
Nara
A R
AR
Green
J A
JA
D000328:Adult; D000368:Aged; D001552:Benzazepines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D018818:Fenoldopam; D005292:Ferricyanides / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D001552:Benzazepines; D005292:Ferricyanides; D014665:Vasodilator Agents; D009599:Nitroprusside; D018818:Fenoldopam